About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Chicago | 17,766 Studies Near You

Clinical TrialsChicago

Clinical Trials in Chicago

Discover 17,766 clinical trials near Chicago, Illinois. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7041-7060 of 17,766 trials

RecruitingA Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in…NCT06312176·Chandler, Arizona and 258 others

Find Trials by Condition in Chicago

Breast Cancerin Chicago Lung Cancerin Chicago Prostate Cancerin Chicago Colorectal Cancerin Chicago Melanomain Chicago Leukemiain Chicago Lymphomain Chicago Pancreatic Cancerin Chicago Ovarian Cancerin Chicago Brain Cancerin Chicago Diabetes

Data from ClinicalTrials.govTerms

CompletedAzacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid LeukemiaThis phase I trial studies the side effects and best dose of azacitidine when given together with cytarabine and mitoxantrone hydrochloride in treating patients with high-risk…NCT01839240·Chicago, Illinois

TerminatedHematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia GravisMG may be neonatal, congenital, or autoimmune. Neonatal MG arises from transplacental transfer of ACh receptor antibodies from a mother with autoimmune MG to the fetus.NCT00424489·Chicago, Illinois

Active not recruitingRho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)A Phase 2a Open-Label Preliminary Safety, Efficacy, and Biomarker Study of WP-0512 in Patients with Amyotrophic Lateral Sclerosis (ALS)NCT05218668·Phoenix, Arizona and 11 others

Active not recruitingSpearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell LiposarcomaThis is a study to investigate the efficacy and safety of ADP-A2M4 in HLA-A\*02 eligible and MAGE-A4 positive subjects with metastatic or inoperable (advanced) Synovial Sarcoma…NCT04044768·Duarte, California and 25 others

CompletedControlling Hyperglycemia Among Minority PopulationThe purpose of this study is to compare the efficacy of three approaches in diabetes management: (1) community health worker (CHW) education; (2) text messaging; and (3) usual…NCT02681718·Chicago, Illinois

CompletedEducation With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node DissectionThis randomized phase III trial studies how well education with or without physical therapy intervention works in preventing lymphedema in women with stage I, II, or III breast…NCT00376597·Castro Valley, California and 75 others

CompletedAtopic Dermatitis Research Network (ADRN) Influenza Vaccine StudyAtopic dermatitis, also called eczema, is a disease in which the skin is dry and scaly with severe itching.NCT01737710·Denver, Colorado and 4 others

TerminatedStudy of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1This will be a Phase 1 Open-label, dose escalation and expansion study of MT-6402 (an Engineered Toxin Body (ETB)) in subjects with advanced solid cancer that expresses PD-L1NCT04795713·Duarte, California and 15 others

CompletedLACTIN-V Study for Recurrent Bacterial VaginosisThis Phase 2b trial is designed to provide a screening evaluation for the hypothesis that, following a 5-day treatment with MetroGel® to treat BV, L. crispatus CTV-05 (LACTIN-V…NCT02766023·San Diego, California and 3 others

CompletedA Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible PatientsThis study will explore 2 different doses of inotuzumab ozogamicin including the dose that is approved and a lower dose.NCT03677596·Los Angeles, California and 44 others

TerminatedEchocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)The EchoCRT trial evaluates the effects of Cardiac Resynchronization Therapy (CRT) on mortality and morbidity of subjects with heart failure due to left ventricular systolic…NCT00683696·Concord, California and 121 others

CompletedManagement of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.This study will examine two questions: 1.NCT00591227·Chicago, Illinois

RecruitingTesting Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaThis phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin helps benefit patients who have received chemotherapy (fludarabine and cyclophosphamide) followed by…NCT05633615·Tucson, Arizona and 94 others

CompletedBevacizumab + CHOP-Rituximab in Untreated Mantle Cell LymphomaPrimary Objective 1\.NCT00401817·Chicago, Illinois and 1 other

CompletedSafety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected PatientsThe purpose of this study is to see if giving tenofovir DF plus a combination of other anti-HIV drugs is safe and effective.NCT00002450·Birmingham, Alabama and 60 others

CompletedThe Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 DrugsTo compare the safety, tolerance, durability of the viral load response and the antiviral activity of the 1592U89/zidovudine(ZDV)/lamivudine (3TC) regimen vs. ZDV/3TC regimen.NCT00002391·Birmingham, Alabama and 29 others

CompletedIdentification of Patient Phenotypes Associated With Elevated Aldosterone LevelsPost-discharge mortality and re-hospitalization for acute heart failure (AHF) affects 15% and 30% of patients respectively, within 90 days.NCT01614860·Chicago, Illinois

Active not recruitingComparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT TrialThis phase III trial compares the effect of adding radiation therapy to usual treatment on the occurrence of bone-related complications in cancer patients with high-risk bone…NCT06745024·Fairbanks, Alaska and 625 others

Active not recruitingEfficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have DiabetesThe primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to semaglutide SC once weekly and to placebo…NCT07284979·Glendale, Arizona and 59 others

PreviousPage 353 of 889Next

in Chicago

Heart Diseasein Chicago